ABSTRACT − Isoflavones have received much attention because of their health-related and clinical benefits such as estrogenic and anti-oxidative activities as well as triggering of natural killer cell activity. However, there are few publications reporting the pharmacokinetic profiles together with physicochemical properties of main isoflavones. Therefore, the pharmacokinetic parameters of main aglycones, daidzein, glycitein and genistein after oral administration of soybean extracts were investigated and the physicochemical properties of soybean extracts were characterized. It was observed that angle of repose was 46 o and tap density, bulk density and porosity were 10.12, 4.3 and 0.86 g/cm 3 and the mean AUC last of daidzein, glycitein and genistein was 11.376 µg·h/mL, 3.045 µg·h/mL and 0.825 µg·h/mL, respectively. Cell viability was 60% at a concentration of 10 mg/mL. Taken together, it was suggested that isoflavones were contained in the soybean products and had an antioxidant activity and this study would be the basis to control the quality of soybean products and study of the bioequivalence between soybean products in future.
Soybeans contain three types of isoflavones, as four chemical forms (aglycons, glycosides, acetylglucosides, and malonylglucosides) (Jian, 2009 ). The major aglycons are daidzein, genistein and glycitein. The major glycosides are genistin, daidzin and glycitin. The acetylglucosides include 6''-O-acetyldaiazin, 6''-O-acetylgenistin and 6''-O-acetylglycitin and the malonylglucosides contain 6''-O-malonyldaiazin, 6''-Omalonylgenistin and 6''-O-malonylglycitin (Vacek et al., 2008) . Isoflavones have received much attention because of their health-related and clinical benefits such as estrogenic and anti-oxidative activities as well as triggering of natural killer cell activity. Particularly, genistein, one of the major isoflavones in Leguminosae, has received great attention as a phytoestrogen demonstrating pharmacological effects such as prevention of hormone-related cancers and bone loss (Zhang et al., 1999) .
Moreover, it is known that the bioavailability of isoflavones from soy-based foods and dietary supplements is a critical component in understanding possible beneficial and adverse effects in animal models and humans (Andrade et al., 2010) . There is general agreement that absorption in the rodent and human gut proceeds by rapid release of aglycones through the action of bacterial and intestinal b-glucosidases following ingestion of isoflavone glucosides present in whole soy foods (Chang and Nair, 1995; Day et al., 2000; Hawksworth et al., 1971; Hosoda et al., 2008; Sfakianos et al., 1997) . Therefore, many manufactures are controlling the final quantity and profile of isoflavones in soybean product by changing soy cultivar (Eldridge and Kwolek, 1983; Seguin et al., 2004) , environmental conditions such as temperature, irrigation and atmospheric CO 2 (Eldridge and Kwolek, 1983; Kim et al., 2005; Rasolohery et al., 2008) , processing (Aguiar et al., 2009; Genovese et al., 2007; Wang et al., 1998; Yin et al., 2005) and storage (Huang and Chou, 2009; Lee et al., 2003) .
After oral administration of genistein with various doses (4, 2, 40 mg/kg) in rats, the bioavailability of genistein was 38.58, 24.34 and 30.75%, respectively. The T max , C max and AUC 0→∞ of genistein after oral administration of genistein (40 mg/kg), were 2 h, 4876.19 ng/mL and 31,269.66 ng·h/mL, respectively (Kwon et al., 2007) . Also, there is a publication that the bioavailability of genistein and daidzein in a mouse model by comparing plasma pharmacokinetics of their aglycones and conjugated forms following administration of identical doses (1.2 mg/kg genistein and 0.55 mg/kg daidzein) by either an intravenous injection or gavage of the aglycones in 90% aqueous solution vs a bolus administration of equimolar doses J. Pharm. Invest., Vol. 40, No. 6 (2010) delivered in a food pellet prepared using commercial soy protein isolate (Andrade et al., 2010) . However, there are few publications reporting the pharmacokinetic profiles of main isoflavones, simultaneously. Therefore, pharmacokinetic parameters of main aglycones, daidzein, glycitein and genistein were studied after oral administration of soybean extracts, the physicochemical properties of soybean extracts were characterized and then in vitro and in vivo correlations were identified in this study.
Materials and Methods

Materials
The standard product of daidzin (040-27741, Wako, Japan), glycitin (077-04691, Wako, Japan), genistin (070-04681, Wako, Japan), daidzein (308-05871, Wako, Japan), glycitein from soybean (070-04701, Wako, Japan) and genistein (446-72-0, Across, USA) was used in this experiment. Soybean extracts (6.724% of daidzin, 2.020% of glycitin, 1.385% of genistin, 0.097% of daidzein, 0.038% of glycitein, 0.013% of genistein) were supplied from Corn Products Korea Co. (Ichon, Korea). All other chemicals were reagent grade and used without further purification.
Cell cultures
Caco-2 cells were purchased from the Korean cell line bank (Seoul, Korea). Caco-2 cells (passage number 46-52) were cultured in DMEM (Dulbecco's Modified Eagle medium) supplemented with 10% FBS, 1% NEAA, 100 units/mL penicillin and 0.1 mg/mL streptomycin in a 5% CO 2 atmosphere with 95% humidity in a 37 o C incubator.
HPLC condition of standard solutions of isoflavones
The mixed solution of standard solutions of isoflavones was prepared and diluted 2, 4, 10 and 100 times at a different concentration. After a result, standard solution consisted of 1.96
196 µg/mL of daidzin and glycitin, 0.784~78.4 µg/mL of genistin, 0.098~9.8 µg/mL of daidzein and glycitein, 0.02452
.45 µg/mL was obtained and then assayed with HPLC (Shimadzu, Japan). The HPLC system was consisted of a Capcell pak C18 column (150 × 4.6 mm, 5 µm; MG120, Shiseido, Tokyo, Japan) thermostated at 30 o C. UV absorption was measured at 254 nm. The mobile phase was consisted of acetonitrile: distilled water: acetic acid (15:85:0.1, v/v %) (A) and acetonitrile: distilled water: acetic acid (35:65:0.1, v/v %) (B), respectively. The flow rate was 1 mL/min and the elution gradient was as follows: 0 min, A of 100%; 30 min, A of 0%; 35 min, A of 50%.
Solubility measurements
An excess amount of soybean extracts was added to microcentrifuge tubes containing 1mL of distilled water, PBS (phosphate buffered solution, pH 7.4) and methanol. The samples were put on an end-to-end labquake rotator (Barnstead Thermolyne, Sparks, NV, USA) at 30 rpm at ambient temperature for 72 h in order to achieve equilibrium. The samples were filtered with a 0.45 µm membrane filter (PALL corpotation, Ann Arbor. USA) and then assayed with HPLC.
Determination of physicochemical properties of soybean extracts
The morphology and surface characteristics of isoflavones were examined by scanning electron microscopy (SEM) (JEOL JSM7500, Thermo, Tokyo, Japan). The samples were mounted onto metal stubs using double-sided adhesive tape onto which the samples were applied. The stubs were sputtercoated with gold particles in a sputter coater for 2 min. On the other hand, the particle size and zeta potential analysis of isoflavones was performed by laser scattering analyzer (ELS-8000, Otasuka Electronics, Osaka, Japan). The extracts were dispersed in water, added to the sample dispersion unit and then sonificated in order to minimize the inter-particle interactions. The obscuration range was maintained between 20~50%. The instrument was set to measure the sample 50 times and the average volume mean diameter was obtained. The physical properties of 100 g of isoflavones such as apparent density, tap density and flowability were measured using BT-1000 (Dandong bettersize instruments Co.) according to the manufacturer's protocol. Briefly, apparent density was determined by the density of powders falling into the container naturally and tap density was measured by the density of powders after compact the powders in the container by vibration. Compaction ratio was calculated using tap density and apparent density.
Cytotoxicity assay
After 72 hours incubation of cells (70% confluent) with isoflavones, the cytotoxicity was determined by MTT assay according to the manufacturer's protocol (Sigma-Aldrich; St. Louis, MO, USA). Briefly, after incubation, MTT (3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl-2H-tetrazolium bromide, Sigma) was added to each well and incubated for 2 h at 37 o C. The crystals of viable cells were solubilized in isopropranolol. The absorbance was determined at 570 nm in a Microplate Reader (Sunrise, Tecan, Austria). Cell viability (%) was represented with the (OD of samples-treated cells divided by OD of cells incubated without samples) × 100.
J. Pharm. Invest., Vol. 40, No. 6 (2010) Animal experiments and drug administration All animal experimental protocols were approved by the Animal Care Committee of Chungnam National University. Male Sprague-Dawley rats weighing 240-260 g were purchased from the Dae Han Laboratory Animal Research Co. (Sunganam, Gyeonggido, Korea). The rats were given commercial rat chow diet (No. 322-7-1) purchased from the Superfeed Co. (Gunsan, Jeollabukdo, Korea) and tap water ad libitum. The animals were housed three per cage in laminar flow cages that were maintained at 22 ± 2 o C, and 50-60% relative humidity. The animals were kept in these facilities for at least one week prior to the experiment and were fasted for at least 24 h before commencing of the experiment. The amount of oral administration of isoflavone into rats was 400 mg/kg. After soybean extracts were dissolved into distilled water, corresponding amount was feed using oral zonde (0.9 × 80 mm, Dongseo, Seoul, Korea). Blood samples (0.6 mL) were collected at 0, 0.25, 0.5, 1, 2, 4, 6, 8 and 12 hour after the administration. The blood samples were centrifuged at 3,000 g for 10 min, and the plasma samples were stored at -70 o C until analyzed by HPLC. The plasma sample (500 µL) was placed into a 15 mL centrifuge tube and then 50 µL of 0.2 M of zinc sulfate solution and 200 µL of acetonitrile were added. After vortexing for 15 min, the mixture was centrifuged at 15000 g for 15 min. The organic phase was transferred to other tubes and evaporated to dryness using a vacuum system. The residues were dissolved in 200 µL of methanol and 10 µL aliquots were injected into the HPLC system for analysis.
Pharmacokinetic analysis
Noncompartmental pharmacokinetic analysis was carried out using the BE computer program, which calculates the AUC (Area under the curve) of the plasma concentration (C p ) as a function of time (t). The maximum plasma concentration (C max ) and the time to reach the maximum plasma concentration (T max ) were obtained from the experimental data. The area under the plasma concentration curve as a function of time (AUC 0-t ) from time zero to the time of the last measured concentration (C last ) was calculated using the linear trapezoidal rule. The AUC zero to infinite (AUC 0→∞ ) was obtained by adding the AUC 0-t , and the extrapolated area was determined by C last /K el . The total plasma clearance (CL/F) was calculated by dividing the dose by the AUC.
Statistical Analysis
The Student's t test was used to compare groups. A p value < 0.05 was considered significant.
Results and Discussion
Solubility measurements
When soybean extracts were dissolved into various solvents, daidzin showed the solubility of 1131.29 ± 45.37 µg/mL in distilled water, 1153.13 ± 20.43 µg/mL in PBS and 1493.28 ± 326.21 µg/mL, respectively. Also, genistin showed the solubility of 576.22 ± 74.37 µg/mL in distilled water, 618.93 ± 3.75 µg/mL in PBS and 536.21 ± 212.17 in methanol. Whileas glycitin exhibited the solubility of 539.01 ± 113.54 µg/mL in distilled water, 482.47 ± 48.47 µg/mL in PBS and 1059.34 ± 59.90 µg/mL in methanol. As above, the solubility of daidzin and genistin according to solvents was indifferent but glycitin showed a high solubility in methanol (Figure 1) . As well as aglycones, daidzein, glycitein and genistein showed the high solubility in distilled water. These results suggested that the solubility had a good relationship with the content of isoflavones in soybean extracts and glycosides such as daidzin, glycitin and genistin did not convert into aglycones such as daidzein, glycitein and genistein in vitro.
Physicochemical and biopharmaceutical characterizations
The morphology of soybean extracts was round at a particle size of 1398 nm and the zeta potential value was -0.13 mV. It was observed that angle of repose was 46 o and tap density, bulk density and porosity were 10.12, 4.3 and 0.86 g/cm 3 , respectively through the determination of the physical property of soybean extracts. Therefore, it was suggested that soybean extracts could be easily filled into capsule and compressed into tablet (Ertani et al., 1997) . On the other hand, cytotoxicity against Caco-2 cells was carried out because soybean extracts were administered orally. It was found that cell viability was 60% at a concentration of 10 mg/mL (Figure 2 ) and suggested Figure 1 . Solubility of main isoflavones in various solvents such as distilled water, PBS and methanol.
J. Pharm. Invest., Vol. 40, No. 6 (2010) this soybean extracts would be non cytotoxic as a habitual diet and nutrients (Jian, 2009 ).
Pharmacokinetic analysis
After oral administration of soybean extracts (400 mg/kg), the plasma concentration of daidzein, glycitein and genistein was determined and daidzin, glycitin and genistin were not detected from rat plasma (Figure 3) . It was proposed that daidzin, glycitin and genistin which are glycosides of daidzein, gylycitein and genistein were attacked by bacterial and intestinal b-glucosidases when ingested into experimental animals. Aglycones such as daidzein, glycitein and genistein were detected with the retention time of 18.50, 19.80 and 26.40 min, respectively, based on the chromatogram and the calibration curve was linear over the concentration range, 0.0098~0.98 µg/ mL of daidzein and glycitein spiked into plasma and 0.02450
.235 µg/mL of genistein spiked into plasma. The corresponding regression curve was y = 38844x+8109.5 (r 2 =0.9789) of daidzein, y = 9867x+1620.5 (r 2 =0.9867) of glycitein and y = 35242x+ 159.41 (r 2 =0.9884) of genistein. The mean peak plasma concentration of daidzein, glycitein and genistein was 2.048 µg/ mL, 0.556 µg/mL and 0.147 µg/mL, respectively (Figure 4) . Also, the mean AUC last of daidzein, glycitein and genistein was 11.376 µg·h/mL, 3.045 µg·h/mL and 0.825 µg·h/mL, respectively ( Table I ). It was known that isoflavones were contained in the soybean products and had an antioxidant activity. It is known that the bioavailability of isoflavones from soy-based foods and dietary supplements is a critical component in understanding possible beneficial and adverse effects in animal models and humans (Andrade et al., 2010) .
Compared with other publications (Kwon et al., 2007) , the T max , C max and AUC 0→∞ of genistein were 0.5 ± 0.1 h, 1124.49 ± 236.40 ng/mL, 3923.03 ± 1531.09 ng·h/mL after oral administration of genistein with 4 mg/kg in rats, meanwhile, our results showed those of genistein were 2.75 ± 3.3 h, 147 ± 20 ng/mL, 825 ± 170 ng·h/mL after oral administration of soybean extracts according to genistein amount of 0.40 ± 0.03 mg/ Figure 2 . Effects of soybean extracts on Caco-2 cell viability. After overnight incubation of cells (70% confluent) with various concentrations of soybean extracts, the cytotoxicity was determined by MTT assay. The cell viability (%) was represented with the (OD of soybean extracts-treated cells divided by OD of cells incubated without soybean extracts) × 100. , Vol. 40, No. 6 (2010) kg in rats, respectively. Because the administered amount and type of genistein were not the same, the direct comparison was difficult. Taken together, aglycones such as daidzein, glycitein and genistein showed the high solubility in distilled water and their oral absorption into rat had a good relationship with the content of soybean extracts. Also, it was supposed that this study would be the basis to study of the bioequivalence between soybean products.
Conclusions
Pharmacokinetic parameters of main aglycones, daidzein, glycitein and genistein were studied after oral administration of soybean extracts and the physicochemical properties of soybean extracts were characterized. Soybean extracts having good physical property could be easily filled into capsule and compressed into tablet. In future, it was suggested that this study would be the basis to study of the bioequivalence between soybean products.
